Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Plx Pharma Inc (PLXP)

6.80 +0.15 (+2.25%)

8/17/2017  11:03am

Open:

6.60

Pre. Close:

6.65

High:

6.80

Low:

6.50

Volume:

13,560

Market Cap:

59.08M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

-

-

Low:

-

-

Close:

-

-

Technical analysis  (as of: 2017-08-17 10:43:55 AM)

Overall:

      

Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.

Target:

Six months: 8.58     One year: 10.03

Support:

Support1: 6.39    Support2: 5.80

Resistance:

Resistance1: 7.35    Resistance2: 8.58

Pivot:

6.54

Moving Averages:

MA(5): 6.46     MA(20): 6.39

MA(100): 7.10     MA(250): 27.42

MACD:

MACD(12,26): 0.10     Signal(12,26,9): 0.09

%K %D:

%K(14,3): 43.69     %D(3): 37.34

RSI:

RSI(14): 56.55

52-Week:

High: 142.01  Low: 5.60  Change(%): -93.3

Average Vol(K):

3-Month: 1299  10-Days 796

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
PLXP has closed below upper band by 31.6%. Bollinger Bands are 33.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

Thu, 10 Aug 2017 20:26:15 GMT
PLx Pharma Inc. Reports Second Quarter 2017 Results

Mon, 12 Jun 2017 10:41:15 GMT
PLx Pharma Inc. Announces Pricing of Registered Direct Offering

Thu, 22 Dec 2016 22:56:47 GMT
Dipexium shares surge on announced merger with PLx Pharma

Sun, 11 Oct 2015 14:56:40 GMT
6.40

Tue, 27 Dec 2016 23:15:43 GMT
Houston-based pharma company to merge with New York-based co.

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

8.68

Shares Float (M)

3.74

% Held by Insiders

% Held by Institutions

Shares Short (K)

32

Shares Short Prior Month (K)

36

Stock Financials

EPS

-0.980

EPS Est. Current Year

-1.450

EPS Est. Next Year

-1.760

EPS Est. Next Quarter

-0.440

Forward EPS

1.#IO

Book Value (p.s.)

-0.810

PEG Ratio

-0.12

Profit Margin

Operating Margin

-26323.03

Return on Assets (ttm)

Return on Equity (ttm)

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.606

Qtrly Earnings Growth

Operating Cash Flow (M)

-3.34

Levered Free Cash Flow (M)

FoxReading.com

Valuation

P/E

-6.89

P/E Growth Ratio

0.02

P/BV

-8.33

P/S

P/CF

-17.54

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

2016-02-12

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2017-04-20

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.